UPC Analytics
ENDE
Overview · Filed: —

ACT_1613/2025

VARIANTS OF C-TYPE NATRIURETIC PEPTIDE

InfringementMain Infringement ActionMunich LDInfringement Action—
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • BioMarin Pharmaceutical Inc.
Reps: Christian Paul (Jones Day); Tobias Mandler (Jones Day); Pascal Grandé (Jones Day)

Respondents

  • Ascendis Pharma A/S
  • Ascendis Pharma Growth Disorders A/S
Reps: Agathe Michel-De Cazotte (Carpmaels & Ransford); Anna Leathley (Carpmaels & Ransford); Daniel Wiese (Carpmaels & Ransford)
Judges
  • Matthias ZigannPresiding Judge / Judge-Rapporteur
  • András KupeczLegally Qualified Judge
  • Tobias PichlmaierLegally Qualified Judge
Patents
  • EP 3 175 863
CPC codes: A61K47/26, G01N2800/52, A61P9/00, A61K47/20, C12N15/70, A61K9/08, A61K47/60, A61K47/10, C07K14/58, G01N2800/105, A61K38/2242, A61K9/19…

Technology area: Biotech · Peptide Therapeutics

Sector: Biotechnology

Outcome
Procedural onlyProcedural only (no substantive ruling yet)
Filed: —
First decided: Jun 2, 2025
Language: —